Reason for request
Inclusion
Clinical Benefit
| Substantial |
Substantial actual benefit |
Clinical Added Value
| no clinical added value |
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection. |
eNq1mF1v2jAUhu/5FVEudkfCZ0u3hGpj7YbUaowWbdoNMsmhmBk79Qcf/fVzCKx0ctTV4MvEyXuOfY4fv3J0uV4QbwlcYEZjvx7UfA9owlJMH2J/dH9d7fiX3Uo0R0t08Nl5UAvqDd9LCBIi9vPRYAKIiuDn7c1n0P8D97sVL2KTOSTyxXdKYhJ8RWJ2i7L8Gy9aMpx6C5AzlsZ+puT2rRcJyXUW3RXjv0WGEojC3ZvD0fm4dfg+CnOx/1BVAvgNog9GUaBWmoniHKjsIQkPjG9K8m1aaWMxBMEUT2CA5GzA2RKnkBpDTBERYBVkukrvgC8JyDyIUTycJwthJY7maD2Ex7456Y96tCfXslqr1s87jbNao13vNGtnVqH4wVKZq6AnESbjervdajWbIdAQNgSQZWUGjEtEHNUEi97LtnIUh8Pjq7VPscgI2gRzkdkuFeJIDwPXm9/dRPIZ3HONI6LX7B99qggJ35j1aAcLRxnnLOoxRWUJM66HtgvRY1TCuryidpiT610vYhCnk31i1Iz4gZoQnNgCTSNHgZCjYb+cZ6dDwSckYMTdseAHpilbidMz5rCmjrLPtpg0imY8rY8bF50zXQbrLfRLN1DJ6XKlOMsg1PTB4hio9OmUHYsT3ZNmqX1HnqgZtw6HJYhAicepWnJFd+Hekjnrc3d7qBgwin65urdtju8K+OZu+2iUxmn8t6x20HVBct2KryVebNo4Gzdr7c5Fs/UOLbIPe/McWxrlQtSJT1bcTJiZlJl4H4ar1SqYIVEVSK9nMOVl/L80TvwUk9ewfa6lOyPv5OgvrFABWkepT4oT9G1FtN22r5mDYw3v7v+dsTbGkFzBEbUoCO+Mw/2r06P92e06S3vwAjDuwmydKZKYUVeeSU2MiscdJrqu9JprQHybTnHJxUppX0ZhcanTrURhfqHTrfwBxyn8vg==
2UWw4WKnvCSbCTcB
